The Aroon Indicator for JSPR entered a downward trend on September 22, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 160 similar instances where the Aroon Indicator formed such a pattern. In of the 160 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on August 29, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on JSPR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
JSPR moved below its 50-day moving average on August 21, 2023 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for JSPR moved below the 200-day moving average on August 24, 2023. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JSPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where JSPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JSPR advanced for three days, in of 108 cases, the price rose further within the following month. The odds of a continued upward trend are .
JSPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.784) is normal, around the industry mean (22.634). P/E Ratio (0.531) is within average values for comparable stocks, (131.508). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.085). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (305.056).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. JSPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
AFMJF | 0.66 | 0.02 | +3.19% |
ALPHAMIN RESOURCES Corp | |||
LISMF | 0.31 | N/A | +0.82% |
Lithium South Dev Corp | |||
PDARX | 10.63 | N/A | N/A |
Principal Diversified Real Asset R6 | |||
KNRRY | 15.47 | -0.02 | -0.10% |
Knorr-Bremse AG American Depositary Receipts - Unsponsored (Germany Federal Republic) | |||
ECHSX | 12.91 | -0.02 | -0.15% |
Eaton Vance Worldwide Health Sci C |
A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with IMVIQ. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then IMVIQ could also see price increases.
Ticker / NAME | Correlation To JSPR | 1D Price Change % | ||
---|---|---|---|---|
JSPR | 100% | +3.83% | ||
IMVIQ - JSPR | 39% Loosely correlated | -4.31% | ||
AUPH - JSPR | 35% Loosely correlated | +0.97% | ||
ALRN - JSPR | 33% Loosely correlated | -0.90% | ||
LBPH - JSPR | 32% Poorly correlated | +0.72% | ||
ATNF - JSPR | 32% Poorly correlated | -4.05% | ||
More |